🇺🇸 FDA
Patent

US 11680070

Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof

granted A61KA61K31/522A61P

Quick answer

US patent 11680070 (Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof) held by Medshine Discovery Inc. expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Medshine Discovery Inc.
Grant date
Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/522, A61P, A61P1/16, A61P17/10